3 FTSE 250 stocks I think could soar into the FTSE 100 index in 2021

From a national institution to a worldwide veterinarian favourite, here are 3 FTSE 250 stocks this Fool thinks could gatecrash the FTSE 100 index this year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m looking today at mid-cap FTSE 250 stocks I think could have the potential to move up into the elite FTSE 100 index. For this to happen, a company’s market capitalisation (share price multiplied by its number of shares in issue) has to pass a certain threshold. Typically, this requires a strong rise in the share price.

The FTSE bods look at the indexes every three months to see if any changes are needed. Right now, there are three FTSE 250 stocks I think have prospects of being promoted to the FTSE 100 during the course of 2021.

ITV (LSE: ITV) will be familiar to most readers. Medical devices group ConvaTec (LSE: CTEC) and veterinary drugs firm Dechra Pharmaceuticals (LSE: DPH) will probably be less familiar.

Blue-chip bounce back

ITV had been a longstanding member of the FTSE 100 before crashing out in last September’s review. Having started 2020 at 150p, the ITV share price had slumped to 57p by the review date.

The Covid-19 pandemic hit the company hard. Shuttered studios and a slump in advertising meant its two main sources of revenue plummeted. However, investors have turned cautiously optimistic since September. We’ve seen a revival in the share price to a current 107p.

As vaccines are rolled out, production and advertising should begin to recover. If this happens, I wouldn’t be surprised to see the ITV share price continue to head back towards 150p. And the company return to the FTSE 100 index.

Of course, if the vaccines rollout doesn’t carry through to a recovery in production and advertising, the ITV share price may not rise.

A lurking FTSE 250 stock

The ConvaTec share price ended 2020 in the same 200p area as it started the year. Mind, it was a volatile journey. The shares briefly went sub-150p in the spring market crash. At today’s 202p, the company lurks outside the FTSE 100.

ConvaTec is a global medical devices group focused on therapies for the management of chronic conditions. The increasing prevalence of such conditions provides a tailwind for the company.

After wholesale boardroom changes a couple of years ago, management is making good progress towards realising ConvaTec’s full potential for profitable growth. Provided progress continues, I think the company could potentially make it into the FTSE 100 index this year.

But this may not happen if progress stalls. For example, by poor execution of the strategy for profitable growth.

Another FTSE 250 stock in contention

The Dechra Pharmaceuticals share price ended 2020 some 17% higher than it started the year. And it’s still rising. At  3,690p, it’s up 7% so far in 2021. After the strong performance, Dechra’s joined ConvaTec within shouting distance of the FTSE 100.

According to the company, the majority of its veterinary products (sold worldwide) are used to treat medical conditions for which there’s no other effective solution. Or have a clinical or dosing advantage over competitor products. The company is growing fast, both organically and by acquisitions.

Dechra’s chief executive has steered the firm for 20 years. Provided he continues to increase the value of the business — and the share price follows suit — I think this is another FTSE 250 stock that could potentially ascend to the FTSE 100 before the year is out.

There’s always risk though, including that Dechra could make a value-destroying, rather than value-enhancing, acquisition. In which case, the share price could fall rather than rise.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended ITV. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »